Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation

Circulation

Volumn 95, Issue 8, 1997, Pages 2003-2006

  Oltrona, Luigi ^a   Broccolino, Marco ^b   Merlini, Piera A ^b   Spinola, Alessandra ^b   Pezzano, Antonio ^b   Mannucci, Pier M ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b NONE

Author keywords

cardioversion; coagulation; fibrillation

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCOAGULABILITY; MALE; PRIORITY JOURNAL; SINUS RHYTHM; THROMBOEMBOLISM; THROMBOGENESIS;

EID: 0030893040     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.8.2003     Document Type: Article

References (16)

1. Goldman MJ. The management of atrial fibrillation: indications for and method of conversion to sinus rhythm. Prog Cardiovasc Dis. 1960;2:465-481.
2. Wolf PA, Dawber TR, Thomas E Jr, Kannel WB. Epidemiological assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology. 1978;28:973-977.
3. Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation. Am J Cardiol. 1969;23:208-216.
4. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol. 1992;19:851-855.
5. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest. 1992;102(suppl):426S-433S.
6. Prystowsky EN, Benson W, Fuster V, Hart RG, Kay GN, Myerburg RJ, Naccarelli GV, Wyse G. Management of patients with atrial fibrillation. Circulation. 1996;93:1262-1277.
7. Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol. 1995;25:452-459.
8. Eisenberg PR, Sherman LA, Schectman K, Perez J, Sobel BE, Jaffe AS. Fibrinopeptide A: a marker of acute coronary thrombosis. Circulation. 1985;71:912-918.
9. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg RD. Persistent activation of the coagulation mechanism in unstable angina and myocardial infarction. Circulation. 1994;90:61-68.
10. Gulba DC, Barthels M, Westhoff-Bleck M, Jost S, Rafflenbleul W, Daniel WG, Hecker H, Lichtlen PR. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Circulation. 1991;83:937-944.
11. Fatkin D. Kuchar DL, Thornburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for 'atrial stunning' as a mechanism of thromboembolic complications. J Am Coll Cardiol. 1994;23:307-316.
12. Black IW, Fatkin D, Sagar KB, Khanderia BK, Leung DY, Galloway JM, Feneley MP, Walsh WF, Grimm RA, Stollberger C, Verhost PM, Klein AL. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. Circulation. 1994;89:2509-2513.
13. Yamamamoto K, Ikeda U, Seino Y, Mito H, Fujikawa H, Sekiguchi H, Shimada K. Coagulation activity is increased in the left atrium of patients with mitral stenosis. J Am Coll Cardiol. 1995;25:107-112.
14. Mugge A, Kuhn H, Daniel WG. The role of transesophageal echocardiography in the detection of left atrial thrombi. Echocardiography. 1993;10:405-417.
15. Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J. 1967;29:469-475.
16. Falcone RA, Morady F, Armstrong WF. Effect of chemical vs electrical cardioversion of atrial fibrillation on left atrial appendage function and spontaneous contrast formation assessed by transesophageal echocardiography. J Am Coll Cardiol. 1995;25:65A.